Lion One Metals (LIO) Stock Chart & Stock Price History C$0.32 -0.01 (-1.52%) (As of 10:42 AM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartEarningsHeadlines Lion One Metals Stock Price Performance5 Day Performance-1.49%1 Month Performance0.00%3 Month Performance+6.45%6 Month Performance-31.96%Year-To-Date Performance-61.18%1 Year Performance-61.18% Receive LIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lion One Metals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Huge AlertsNASDAQ small cap that could be gearing up for a massive short squeeze.A Heavy Short Interest Could Lead to a Monstrous Short Squeeze for this Tiny NASDAQ Healthcare Firm!See how this NASDAQ Bio-tech is offering viable solutions LIO Stock Chart for Tuesday, November, 5, 2024 LIO Chart by TradingView Lion One Metals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/04/2024C$0.33C$0.33C$0.34C$0.3345,555 shsC$86.47 million11/01/2024C$0.34C$0.33-1.49%C$0.34C$0.3335,690 shsC$86.47 million10/31/2024C$0.35C$0.34-2.90%C$0.34C$0.33228,226 shsC$87.78 million10/30/2024C$0.35C$0.35-1.43%C$0.35C$0.35323,000 shsC$90.40 million10/29/2024C$0.35C$0.35+1.45%C$0.36C$0.35210,075 shsC$91.71 million10/28/2024C$0.35C$0.35-1.43%C$0.35C$0.34363,000 shsC$90.40 million Get the Latest News and Ratings for LIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lion One Metals and its competitors with MarketBeat's FREE daily newsletter. 10/25/2024C$0.34C$0.35+2.94%C$0.35C$0.34232,550 shsC$91.71 million10/24/2024C$0.35C$0.34-2.86%C$0.35C$0.34189,650 shsC$89.09 million10/23/2024C$0.36C$0.35-2.78%C$0.36C$0.34197,726 shsC$91.71 million10/22/2024C$0.35C$0.36+2.86%C$0.37C$0.342.04 million shsC$94.33 million10/21/2024C$0.36C$0.35-2.78%C$0.37C$0.35877,534 shsC$91.71 million10/18/2024C$0.36C$0.36C$0.38C$0.35569,395 shsC$94.33 million10/17/2024C$0.36C$0.36C$0.37C$0.36280,293 shsC$94.33 million10/16/2024C$0.35C$0.36+2.86%C$0.36C$0.35319,884 shsC$94.33 million10/15/2024C$0.34C$0.35+2.94%C$0.36C$0.34330,963 shsC$91.71 million10/14/2024C$0.34C$0.34C$0.36C$0.33347,031 shsC$89.09 million10/11/2024C$0.34C$0.34+1.49%C$0.36C$0.33347,031 shsC$89.09 million10/10/2024C$0.32C$0.34+6.35%C$0.34C$0.32146,465 shsC$87.78 million10/09/2024C$0.33C$0.32-3.08%C$0.32C$0.31424,350 shsC$82.54 million10/08/2024C$0.33C$0.33-1.52%C$0.34C$0.32165,950 shsC$85.16 million10/07/2024C$0.33C$0.33C$0.33C$0.33662,505 shsC$86.47 million10/04/2024C$0.33C$0.33+1.54%C$0.34C$0.331.10 million shsC$86.47 million10/03/2024C$0.32C$0.33+3.17%C$0.33C$0.32252,088 shsC$85.16 million10/02/2024C$0.32C$0.32-1.56%C$0.33C$0.32239,690 shsC$82.54 million10/01/2024C$0.35C$0.32-8.57%C$0.35C$0.32893,276 shsC$83.85 million09/30/2024C$0.34C$0.35+2.94%C$0.35C$0.34431,784 shsC$91.71 million09/27/2024C$0.34C$0.34+1.49%C$0.34C$0.33397,481 shsC$89.09 million09/26/2024C$0.32C$0.34+4.69%C$0.34C$0.33795,084 shsC$87.78 million09/25/2024C$0.32C$0.32C$0.33C$0.32184,065 shsC$83.85 million09/24/2024C$0.32C$0.32+1.59%C$0.32C$0.32384,309 shsC$83.85 million09/23/2024C$0.32C$0.32-1.56%C$0.33C$0.32529,715 shsC$82.54 million09/20/2024C$0.32C$0.32+1.59%C$0.33C$0.32652,292 shsC$83.85 million09/19/2024C$0.31C$0.32+3.28%C$0.32C$0.31639,046 shsC$82.54 million09/18/2024C$0.31C$0.31C$0.32C$0.30651,024 shsC$79.92 million09/17/2024C$0.31C$0.31-1.61%C$0.32C$0.30210,570 shsC$79.92 million09/16/2024C$0.31C$0.31+1.64%C$0.32C$0.31265,332 shsC$81.23 million09/13/2024C$0.29C$0.31+5.17%C$0.31C$0.291.34 million shsC$79.92 million09/12/2024C$0.28C$0.29+3.57%C$0.30C$0.28498,060 shsC$75.99 million09/11/2024C$0.28C$0.28+1.82%C$0.28C$0.27292,094 shsC$73.37 million09/10/2024C$0.28C$0.28-1.79%C$0.28C$0.27177,397 shsC$72.06 millionNASDAQ traded stock with a BIG short position. (Ad)Small cap NASDAQ firm is an innovative leader in non-opioid pain therapeutics. The company’s offerings could significantly aid in stopping the opioid crisis and create maximum shareholder growth!See how this NASDAQ Bio-tech is offering viable solutions09/09/2024C$0.28C$0.28C$0.29C$0.28188,009 shsC$73.37 million09/06/2024C$0.28C$0.28C$0.29C$0.28207,952 shsC$73.37 million09/05/2024C$0.28C$0.28C$0.29C$0.28495,429 shsC$73.37 million09/04/2024C$0.29C$0.28-1.75%C$0.29C$0.28378,004 shsC$73.37 million09/03/2024C$0.30C$0.29-3.39%C$0.30C$0.29383,859 shsC$74.68 million09/02/2024C$0.30C$0.30C$0.30C$0.30150,366 shsC$77.30 million08/30/2024C$0.30C$0.30C$0.30C$0.30150,366 shsC$77.30 million08/29/2024C$0.30C$0.30C$0.30C$0.29224,525 shsC$77.30 million08/28/2024C$0.31C$0.30-4.84%C$0.32C$0.29655,771 shsC$77.30 million08/27/2024C$0.31C$0.31C$0.32C$0.31179,440 shsC$81.23 million08/26/2024C$0.31C$0.31C$0.32C$0.31386,820 shsC$81.23 million08/23/2024C$0.32C$0.31-3.13%C$0.32C$0.31246,500 shsC$81.23 million08/22/2024C$0.34C$0.32-4.48%C$0.34C$0.32521,536 shsC$83.85 million08/21/2024C$0.33C$0.34+3.08%C$0.34C$0.32385,432 shsC$87.78 million08/20/2024C$0.35C$0.33-5.80%C$0.36C$0.32868,558 shsC$85.16 million08/19/2024C$0.32C$0.35+7.81%C$0.35C$0.321.31 million shsC$90.40 million08/16/2024C$0.31C$0.32+3.23%C$0.32C$0.31870,200 shsC$83.85 million08/15/2024C$0.32C$0.31-1.59%C$0.31C$0.31314,075 shsC$81.23 million08/14/2024C$0.31C$0.32+2.27%C$0.32C$0.31292,695 shsC$82.54 million08/13/2024C$0.30C$0.31+2.67%C$0.31C$0.30602,314 shsC$80.71 million08/12/2024C$0.29C$0.30+3.45%C$0.30C$0.29377,858 shsC$78.61 million08/09/2024C$0.29C$0.29C$0.30C$0.29547,266 shsC$75.99 million08/08/2024C$0.29C$0.29C$0.30C$0.29364,333 shsC$66.86 million08/07/2024C$0.29C$0.29C$0.30C$0.29672,164 shsC$66.86 million08/06/2024C$0.31C$0.29-6.45%C$0.32C$0.29503,419 shsC$66.86 million08/05/2024C$0.31C$0.31C$0.33C$0.30852,470 shsC$71.47 million Related Companies ATEX Resources Stock Chart Collective Mining Stock Chart Osino Resources Stock Chart Probe Gold Stock Chart Osisko Development Stock Chart Tudor Gold Stock Chart GoldMining Stock Chart Lumina Gold Stock Chart Rio2 Stock Chart Steppe Gold Stock Chart Receive LIO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lion One Metals and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:LIO) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lion One Metals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Lion One Metals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
